SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-21-005123
Filing Date
2021-01-25
Accepted
2021-01-25 17:11:16
Documents
2
Period of Report
2021-01-21

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1614
2 POA DOCUMENT poa.txt EX-24.3_957471 4747
  Complete submission text file 0001209191-21-005123.txt   7979
Mailing Address 10975 N. TORREY PINES RD., #150 LA JOLLA CA 92037
Business Address 10975 N. TORREY PINES RD., #150 LA JOLLA CA 92037 858-401-7900
Avidity Biosciences, Inc. (Issuer) CIK: 0001599901 (see all company filings)

IRS No.: 461336960 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O AVIDITY BIOSCIENCES, INC. 10975 N. TORREY PINES RD., SUITE 150 LA JOLLA CA 92037
Business Address
Flanagan W. Michael (Reporting) CIK: 0001841990 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39321 | Film No.: 21550694